Home › Trial NCT01074138
Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer
- Trial IDNCT01074138
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorAthenex, Inc.
- Enrollment31
- Start date2010-02
- ConditionsBone-Metastatic, Castration-Resistant Prostate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.